Ulysses Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.22M | Hold |
|
|||||
|
2024
Q4 | $1.35M | Sell |
|
|||||
|
2024
Q3 | $2.12M | Buy |
|
|||||
|
2024
Q2 | $1.62M | Hold |
|
|||||
|
2024
Q1 | $1.66M | Buy |
|
|||||
|
2023
Q4 | $402K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.25M | Sell |
|
|||||
|
2023
Q1 | $1.33M | Buy |
|
|||||
|
2022
Q4 | $1.4M | Buy |
|
|||||
|
2022
Q3 | $397K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $771K | Buy |
|
|||||
|
2017
Q1 | – | Hold |
|